AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11083272 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 248
Study 11083272 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Number of subjects: 248
Study 11083272 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose penicillamine
Number of subjects: 248
Study 11083272 — intervention group
Group type: COMPARATOR
Intervention: Low-dose penicillamine
Number of subjects: 248
Study 11083272 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for minocycline)
Number of subjects: 248
Study 11083272 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for sulfasalazine)
Number of subjects: 248
Study 8653991 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine metabolite ratio AAMU + 1U + 1X/17U
Number of subjects: 21
Study 8653991 — intervention group
Group type: EXPERIMENTAL
Intervention: Other caffeine metabolite ratios
Number of subjects: 21
Study 1598960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 10
Study 1598960 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 10
Study 6398982 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar gum (21 g per day, taken with meals three times a day)
Number of subjects: 17
Study 6398982 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar gum
Number of subjects: 17
Study 6398982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 30539193 — intervention group
Group type: EXPERIMENTAL
Intervention: Health check and lifestyle intervention
Number of subjects: 11483
Study 30539193 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11483
Study 29471158 — intervention group
Group type: EXPERIMENTAL
Intervention: Road traffic injuries (RTI)
Number of subjects: 13765
Study 29471158 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare seeking behavior
Number of subjects: 13765
Study 29471158 — intervention group
Group type: EXPERIMENTAL
Intervention: Major procedures
Number of subjects: 13765
Study 29471158 — intervention group
Group type: EXPERIMENTAL
Intervention: Major disability
Number of subjects: 13765
Study 26953023 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior chamber Artisan IOL implantation
Number of subjects: 40
Study 26953023 — intervention group
Group type: COMPARATOR
Intervention: Retropupillary Artisan IOL implantation
Number of subjects: 40
Study 25345628 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel (PER) 4 mg/day
Number of subjects: 1478
Study 25345628 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel (PER) 8 mg/day
Number of subjects: 1478
Study 25345628 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel (PER) 12 mg/day
Number of subjects: 1478
Study 25345628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1478
Study 25345628 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel (PER) long-term treatment (10 or 12 mg/day)
Number of subjects: 1478
Study 25345628 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (AEs) with any dose of PER
Number of subjects: 1478
Study 22889651 — intervention group
Group type: EXPERIMENTAL
Intervention: Star Excursion Balance Test (SEBT)
Number of subjects: 20
Study 22889651 — intervention group
Group type: COMPARATOR
Intervention: Y Balance Test (YBT)
Number of subjects: 20
Study 20620267 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (1mg/day to 6mg/day)
Number of subjects: 26
Study 17631904 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, high-protein diet
Number of subjects: 32
Study 17631904 — intervention group
Group type: COMPARATOR
Intervention: Low-fat control diet
Number of subjects: 32
Study 16599033 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.1‐0.2 mg kg(‐1)
Number of subjects: 150
Study 16599033 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine 0.1‐0.2 mg kg(‐1)
Number of subjects: 150
Study 16599033 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% Dextrose and normal saline 2ml)
Number of subjects: 150
Study 12374446 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad mood condition with cognitive load task
Number of subjects: 0
Study 12374446 — intervention group
Group type: COMPARATOR
Intervention: Induced sadness
Number of subjects: 0
Study 12374446 — intervention group
Group type: COMPARATOR
Intervention: Sad participants
Number of subjects: 0
Study 12374446 — intervention group
Group type: COMPARATOR
Intervention: Higher Beck Depression Inventory scores
Number of subjects: 0
Study 9929022 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA (6 mg/kg intravenous infusion)
Number of subjects: 16
Study 9929022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9929022 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA
Number of subjects: 16
Study 7478254 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine (THA) 75 mg
Number of subjects: 0
Study 7478254 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine (THA) 25 mg
Number of subjects: 0
Study 7478254 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine (THA) 25 or 75 mg
Number of subjects: 0
Study 2123433 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin plus multi-vitamins infusions
Number of subjects: 41
Study 2123433 — intervention group
Group type: COMPARATOR
Intervention: Placebo (multi-vitamins alone)
Number of subjects: 41
Study 6966331 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 132
Study 6966331 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 132
Study 31808248 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus commercial weight management sessions commencing 8-16 weeks postnatally
Number of subjects: 193
Study 31808248 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 193
Study 30772006 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrectomy
Number of subjects: 317
Study 30772006 — intervention group
Group type: COMPARATOR
Intervention: Open gastrectomy
Number of subjects: 317
Study 28081673 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir plus lamivudine (dual therapy)
Number of subjects: 44
Study 28081673 — intervention group
Group type: COMPARATOR
Intervention: lopinavir/ritonavir plus 2 NRTI (triple therapy)
Number of subjects: 44
Study 25882763 — intervention group
Group type: EXPERIMENTAL
Intervention: ziprasidone
Number of subjects: 49
Study 25882763 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 49
Study 24066805 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic Motivation and Training program (PMT)
Number of subjects: 90
Study 24066805 — intervention group
Group type: COMPARATOR
Intervention: One session of advice in exercise training (EX)
Number of subjects: 90
Study 24066805 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 90
Study 21848443 — intervention group
Group type: EXPERIMENTAL
Intervention: X(A) - progressive high-intensity exercise (≥ 75% maximum heart rate) with nutrition and parent education sessions
Number of subjects: 27
Study 21848443 — intervention group
Group type: COMPARATOR
Intervention: O(B) - control group
Number of subjects: 27
Study 19480863 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-bearing (WB) exercise
Number of subjects: 106
Study 19480863 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonweight-bearing (NWB) exercise
Number of subjects: 106
Study 19480863 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 106
Study 17252032 — intervention group
Group type: EXPERIMENTAL
Intervention: National Upper Cervical Chiropractic (NUCCA) procedure
Number of subjects: 50
Study 17252032 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure (placebo)
Number of subjects: 50
Study 15131536 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent placement
Number of subjects: 10347
Study 15131536 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 10347
Study 11359763 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil (20 mg twice daily)
Number of subjects: 5000
Study 11359763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5000
Study 11359763 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 5000
Study 9424198 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of phytoadaptogen (Adapt)
Number of subjects: 5
Study 8221501 — intervention group
Group type: EXPERIMENTAL
Intervention: Meeting a person with AIDS in the classroom (treatment group)
Number of subjects: 4
Study 8221501 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no meeting with a person with AIDS)
Number of subjects: 4
Study 3624149 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (T)
Number of subjects: 10
Study 3624149 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprofylline (E)
Number of subjects: 10
Study 31580698 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive Tecar Therapy (TT)
Number of subjects: 10
Study 31580698 — intervention group
Group type: EXPERIMENTAL
Intervention: Capacitive Tecar Therapy (TT)
Number of subjects: 10
Study 31580698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29392530 — intervention group
Group type: EXPERIMENTAL
Intervention: LANAP
Number of subjects: 15
Study 29392530 — intervention group
Group type: COMPARATOR
Intervention: ENAP
Number of subjects: 15
Study 27124042 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon gamma release assay (IGRA)
Number of subjects: 150
Study 27124042 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculin skin test (TST)
Number of subjects: 150
Study 27124042 — intervention group
Group type: COMPARATOR
Intervention: Comparison of IGRA and TST
Number of subjects: 150
Study 25344693 — intervention group
Group type: EXPERIMENTAL
Intervention: AHP-SF (short-form Adolescent Health Promotion Scale)
Number of subjects: 814
Study 25344693 — intervention group
Group type: EXPERIMENTAL
Intervention: AHP-SF
Number of subjects: 814
Study 23216418 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour stories
Number of subjects: 20
Study 23216418 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication stories
Number of subjects: 20
Study 20395973 — intervention group
Group type: EXPERIMENTAL
Intervention: DisCoVisc
Number of subjects: 323
Study 20395973 — intervention group
Group type: COMPARATOR
Intervention: Healon5
Number of subjects: 323
Study 18925430 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant HCG (rHCG) - 250 microg subcutaneous injection
Number of subjects: 89
Study 18925430 — intervention group
Group type: COMPARATOR
Intervention: Urinary HCG (uHCG) - 10,000 IU intramuscular injection
Number of subjects: 89
Study 15672335 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 microg/kg naloxone
Number of subjects: 131
Study 15672335 — intervention group
Group type: COMPARATOR
Intervention: 0.10 mg/kg morphine IV bolus
Number of subjects: 131
Study 12938130 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 T
Number of subjects: 25
Study 12938130 — intervention group
Group type: COMPARATOR
Intervention: 8 T
Number of subjects: 25
Study 10497374 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutter valve
Number of subjects: 23
Study 10497374 — intervention group
Group type: COMPARATOR
Intervention: CPT
Number of subjects: 23
Study 8759532 — intervention group
Group type: EXPERIMENTAL
Intervention: Otovent treatment set
Number of subjects: 0
Study 8759532 — intervention group
Group type: COMPARATOR
Intervention: Valsalva manoeuvre
Number of subjects: 0
Study 2012010 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg palmvitee capsules/day
Number of subjects: 15
Study 2012010 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg gamma-tocotrienol/d
Number of subjects: 15
Study 2012010 — intervention group
Group type: COMPARATOR
Intervention: 300 mg corn oil/d
Number of subjects: 15
Study 7081191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine treatment
Number of subjects: 0
Study 7081191 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study 6428260 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP/CPAP
Number of subjects: 64
Study 6428260 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP/O2-catheter
Number of subjects: 64
Study 6428260 — intervention group
Group type: EXPERIMENTAL
Intervention: ZEEP/CPAP
Number of subjects: 64
Study 6428260 — intervention group
Group type: EXPERIMENTAL
Intervention: ZEEP/O2-catheter
Number of subjects: 64
Study 6428260 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra- and post-operative increase in airway pressure
Number of subjects: 64
Study 29289383 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg-1018 (HEPLISAV-B™) administered intramuscularly at weeks 0 and 4
Number of subjects: 8374
Study 29289383 — intervention group
Group type: COMPARATOR
Intervention: HBsAg-Eng (Engerix-B®) administered at weeks 0, 4, and 24
Number of subjects: 8374
Study 29289383 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg-1018 (HEPLISAV-B™) in total study population (N=6826)
Number of subjects: 8374
Study 29289383 — intervention group
Group type: COMPARATOR
Intervention: HBsAg-Eng (Engerix-B®) in total study population (N=6826)
Number of subjects: 8374
Study 26968277 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (5.6 g/day)
Number of subjects: 23
Study 26968277 — intervention group
Group type: COMPARATOR
Intervention: Oral paraffin (placebo)
Number of subjects: 23
Study 24504775 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 131
Study 22228325 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal/esophageal traction exercise (TTE) treatment for 3 consecutive days before surgery
Number of subjects: 0
Study 22228325 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TTE treatment)
Number of subjects: 0
Study 19306024 — intervention group
Group type: EXPERIMENTAL
Intervention: Myrtle oral paste applied four times a day for 6 days
Number of subjects: 45
Study 19306024 — intervention group
Group type: COMPARATOR
Intervention: Placebo paste
Number of subjects: 45
Study 18366729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP) in combination with medication
Number of subjects: 160
Study 18366729 — intervention group
Group type: COMPARATOR
Intervention: Usual secondary care in combination with medication
Number of subjects: 160
Study 16113617 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU SSRI plus brief cognitive-behavioral therapy (CBT) (n = 77)
Number of subjects: 152
Study 16113617 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) control condition (n = 75)
Number of subjects: 152
Study 12455393 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycobacterium w plus HAART
Number of subjects: 50
Study 12455393 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycobacterium w alone
Number of subjects: 50
Study 12455393 — intervention group
Group type: COMPARATOR
Intervention: Mycobacterium w plus two antiretroviral agents
Number of subjects: 50
Study 10521835 — intervention group
Group type: EXPERIMENTAL
Intervention: Early amniocentesis (11 + 0‐14 + 6 weeks)
Number of subjects: 2924
Study 10521835 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional mid‐trimester amniocentesis (15 + 0‐18 + 6 weeks)
Number of subjects: 2924
Study 10521835 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniocentesis after 18 + 6 weeks' gestation
Number of subjects: 2924
Study 10521835 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative miscarriage risk after early amniocentesis
Number of subjects: 2924
Study 10521835 — intervention group
Group type: EXPERIMENTAL
Intervention: Early amniocentesis
Number of subjects: 2924
Study 10521835 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional mid‐trimester amniocentesis
Number of subjects: 2924
Study 10521835 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniocentesis after 19 weeks' gestation
Number of subjects: 2924
Study 7793224 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 30 micrograms kg‐1
Number of subjects: 24
Study 7793224 — intervention group
Group type: COMPARATOR
Intervention: Physiologic saline (Control)
Number of subjects: 24
Study 2029855 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial electric treatment (TET) with constant current and pulse current of square impulses of 70-80 Hz
Number of subjects: 0
Study 2029855 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 7332089 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol-HCl continuous infusion
Number of subjects: 0
Study 31283989 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (tDCS)
Number of subjects: 14
Study 31283989 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 14
Study 30124459 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy (30 min per session, 5 sessions per week for 8 weeks)
Number of subjects: 30
Study 30124459 — intervention group
Group type: COMPARATOR
Intervention: General occupational therapy (30 min per session, 5 sessions per week for 8 weeks)
Number of subjects: 30
Study 26914592 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-titrating CPAP (n=122)
Number of subjects: 244
Study 26914592 — intervention group
Group type: COMPARATOR
Intervention: No positive airway pressure (n=122)
Number of subjects: 244
Study 26914592 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP usage for ≥4 hours per night
Number of subjects: 244
Study 26914592 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP usage for <4 hours per night or no treatment
Number of subjects: 244
Study 24532004 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloader knee orthosis
Number of subjects: 7
Study 22309059 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated presentation (Experiments 1 and 3)
Number of subjects: 0
Study 22309059 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated-with-labels presentation (Experiment 2)
Number of subjects: 0
Study 22309059 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated groups (Experiments 1 and 2)
Number of subjects: 0
Study 22309059 — intervention group
Group type: COMPARATOR
Intervention: Separated groups (Experiments 1 and 2)
Number of subjects: 0
Study 20236911 — intervention group
Group type: EXPERIMENTAL
Intervention: Quartz‐tungstenhalogen (QTH) curing unit (400 mW/cm2) for 20 seconds
Number of subjects: 40
Study 20236911 — intervention group
Group type: EXPERIMENTAL
Intervention: Quartz‐tungstenhalogen (QTH) curing unit (400 mW/cm2) for 40 seconds
Number of subjects: 40
Study 20236911 — intervention group
Group type: EXPERIMENTAL
Intervention: Light‐emitting‐diode (LED) curing unit (180 mW/cm2) for 20 seconds
Number of subjects: 40
Study 20236911 — intervention group
Group type: EXPERIMENTAL
Intervention: Light‐emitting‐diode (LED) curing unit (180 mW/cm2) for 40 seconds
Number of subjects: 40
Study 20236911 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol storage for 24 hours
Number of subjects: 40
Study 17317364 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-wave myocardial infarction (MI)
Number of subjects: 1221
Study 17317364 — intervention group
Group type: EXPERIMENTAL
Intervention: Conduction abnormalities
Number of subjects: 1221
Study 17317364 — intervention group
Group type: COMPARATOR
Intervention: Non-Q-wave MI
Number of subjects: 1221
Study 15674491 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse incision laparotomy
Number of subjects: 94
Study 15674491 — intervention group
Group type: COMPARATOR
Intervention: Midline incision laparotomy
Number of subjects: 94
Study 11888402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonus financial incentive
Number of subjects: 50
Study 11888402 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced fee-for-service financial incentive
Number of subjects: 50
Study 11888402 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 11888402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonus group (immunizations given by others)
Number of subjects: 50
Study 9596431 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized glucagon (2 mg)
Number of subjects: 10
Study 9596431 — intervention group
Group type: COMPARATOR
Intervention: Nebulized saline (placebo)
Number of subjects: 10
Study 7946899 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 micrograms/d for 8 weeks)
Number of subjects: 0
Study 7946899 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3042994 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous regular insulin (0.0, 0.5, 1.0, 2.0, 3.0, and 4.0 units)
Number of subjects: 6
Study 3042994 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous regular insulin (various doses)
Number of subjects: 6
Study 30836228 — intervention group
Group type: EXPERIMENTAL
Intervention: ELLIPTA
Number of subjects: 0
Study 30836228 — intervention group
Group type: COMPARATOR
Intervention: MDI-1
Number of subjects: 0
Study 30836228 — intervention group
Group type: COMPARATOR
Intervention: MDI-2
Number of subjects: 0
Study 30836228 — intervention group
Group type: COMPARATOR
Intervention: MDI
Number of subjects: 0
Study 28619274 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation of Modified Dental Anxiety Scale (MDAS) score sheet to the dentist
Number of subjects: 0
Study 28619274 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation of MDAS to the dentist with open response to patient fears
Number of subjects: 0
Study 26349115 — intervention group
Group type: EXPERIMENTAL
Intervention: Garenoxacin 200 mg
Number of subjects: 20
Study 26349115 — intervention group
Group type: EXPERIMENTAL
Intervention: Garenoxacin 400 mg
Number of subjects: 20
Study 23131836 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted swallowing therapy (VAST)
Number of subjects: 42
Study 23131836 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 42
Study 21905793 — intervention group
Group type: EXPERIMENTAL
Intervention: TachoComb
Number of subjects: 120
Study 21905793 — intervention group
Group type: COMPARATOR
Intervention: Control (no hemostatic agents)
Number of subjects: 120